Business Description DNAPRINT GENOMICS INC (DNAP) is a young e-biotech company developing an informatics platform system that will provide dynamic solutions for disease gene discovery, genetic predisposition and genetic analysis testing. Their work has real-life application to the germinating field of Personalized Medicine and will help lay the foundation for a brand-new area of medical research called Phenomics. The PhenomeSM platform system they are developing will help identify an individual predisposed to develop cancer before the onset of illness so that lifestyles can be altered and/or preventative measures taken. It will be used to identify individuals who are incompatible with certain drug treatments before the drugs are prescribed and damage is done. It will be used to tease out important genetic determinants associated with complex genetic diseases, so that drugs can be developed to target these genes.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.